Abstract
Both mania and bipolar depression have been associated with decrements in the activity of the sodium and potassium-activated adenosine triphosphatase (Na,K-ATPase) membrane pump. Although the role of this observation in the pathophysiology of bipolar illness is unclear, it has been proposed that this defect could be central to the pathogenesis of the illness. In an effort to test this hypothesis, the authors examined the efficacy of lithium pretreatment in attenuating behavioral changes secondary to acute administration of a single intracerbroventricular (icv) dose of the Na,K-ATPase-inhibiting compound, ouabain, in the Sprague-Dawley rat. Ouabain (10−3 M) significantly decreased motor activity in automated activity monitors. Lithium pretreatment for 7 d totally prevented this effect. These preliminary data suggest that icv ouabain administration in the rat may prove to be a viable animal model for bipolar illness.
Similar content being viewed by others
References
Batterman R. C. and Gutner L. B. (1948) Hitherto undescribed neurological manifestations of digitalis toxicity.Am. Heart J. 36, 582–586.
Changaris D. G., Porter J. L., Miller J. J., and Levy R. S. (1988) Des-Leu angiotensin I: biosynthesis and drinking response.Regul. Pept. 20, 273–280.
Christmas A. J. and Maxwell D. R. (1970) A comparison of the effects of some benzodiazepines and other drugs on aggressive and exploratory behaviour in mice and rats.Neuro-pharmacol. 9, 17–29.
Eisendrath S. T. and Sweeney M. A. (1987) Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations.Am. J. Psychiatry 144, 506–507.
El-Mallakh R. S., Barrett J. L., and Wyatt R. J. (1993a) The Na,K-ATPase hypothesis for bipolar disorder: Implications of normal development.J. Child Adolesc. Psychopharmacol. 3, 37–52.
El-Mallakh R. S., Harrison L. T., Changaris D. G., and Levy R. S. (1993b) An animal model for bipolar illness.Soc. Neurosci. Abstracts 340:18, 840.
El-Mallakh R. S., Harrison L. T., Li R., Changaris D. G., and Levy R. S. (1995a) An animal model for mania: Preliminary results.Prog. Neuro-Psychopharmacol. Biol. Psychiatry 19, 955–962.
El-Mallakh R. S., Hedges S., and Casey D. (1995b) Digoxin encephalopathy presenting as mood disturbance.J. Clin. Psychopharmacol. 15, 82–83.
El-Mallakh R. S. and Li R. (1993) Is the Na+-K+-ATPase the link between phosphoinositide metabolism and bipolar disorder?J. Neuropsychiatry Clin. Neurosci. 5, 361–368.
El-Mallakh R. S. and Wyatt R. J. (1995) The Na,K-ATPase hypothesis for bipolar illness.Biol. Psychiatry 37, 235–244.
Goodwin F. K. and Jamison K. R. (1990)Manic-Depressive Illness. Oxford, New York.
Hayden J. F., Johnson L. R., and Maickel R. P. (1966) Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain.Life Sci. 5, 1509–1515.
Levy R. S., El-Mallakh R. S., Li R., Harrison L. T., and Changaris D. G. (1995) An animal model for bipolar illness: Effects of lithium. Presented at the Sixth Annual Spring Brain Conference, March 1–5, Sedona, Az, Abstract No. 8.3.
Li R., Wing L. L., Wyatt R. J., and Kirch D. G. (1993) Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain.Pharmacol. Biochem. Behav. 46, 323–329.
Looney S. W. and El-Mallakh R. S. (1995) A meta-analysis of Na,K-ATPase activity in bipolar illness. Presented at the Spring Meeting of the Biometric Society, March 26–29, Birmingham, AL.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, R., El-Mallakh, R.S., Harrison, L. et al. Lithium prevents ouabain-induced behavioral changes. Molecular and Chemical Neuropathology 31, 65–72 (1997). https://doi.org/10.1007/BF02815161
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02815161